Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Simona Rodighiero"'
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 6, Pp n/a-n/a (2023)
Abstract MYC is a key oncogenic driver in multiple tumor types, but concomitantly endows cancer cells with a series of vulnerabilities that provide opportunities for targeted pharmacological intervention. For example, drugs that suppress mitochondria
Externí odkaz:
https://doaj.org/article/dd1aad8474044a6a872abca328cab2af
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
Autor:
Giulio Donati, Micol Ravà, Marco Filipuzzi, Paola Nicoli, Laura Cassina, Alessandro Verrecchia, Mirko Doni, Simona Rodighiero, Federica Parodi, Alessandra Boletta, Christopher P. Vellano, Joseph R. Marszalek, Giulio F. Draetta, Bruno Amati
Publikováno v:
Molecular Oncology, Vol 16, Iss 5, Pp 1132-1152 (2022)
Multiple molecular features, such as activation of specific oncogenes (e.g., MYC, BCL2) or a variety of gene expression signatures, have been associated with disease course in diffuse large B‐cell lymphoma (DLBCL), although their relationships and
Externí odkaz:
https://doaj.org/article/25494cefbbb1465b908303161ee213bd
Autor:
Claudia Bazzini, Lorena Benedetti, Davide Civello, Chiara Zanoni, Valeria Rossetti, Davide Marchesi, Maria Lisa Garavaglia, Markus Paulmichl, Maura Francolini, Giuliano Meyer, Simona Rodighiero
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108826 (2014)
To optimise the efficiency of cell machinery, cells can use the same protein (often called a hub protein) to participate in different cell functions by simply changing its target molecules. There are large data sets describing protein-protein interac
Externí odkaz:
https://doaj.org/article/c10fc36264be49f6b6f09d261c313d6b
Autor:
Anna Mondini, Francesca Sassone, Davide Antonio Civello, Maria Lisa Garavaglia, Claudia Bazzini, Simona Rodighiero, Valeria Vezzoli, Fabio Conti, Lucia Torielli, Giovanbattista Capasso, Markus Paulmichl, Giuliano Meyer
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52014 (2012)
The CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) activity and localization are influenced by the cytoskeleton, in particular by actin and its polymerization state. In this study we investigated whether the expression of the hypertensive
Externí odkaz:
https://doaj.org/article/6735831937cf49f08824b3b3d5796d9c
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
Publikováno v:
EMBO Molecular Medicine.
Autor:
Bruno A Duso, Elena Gavilán Dorronzoro, Giulia Tini, Maria R de Filippo, Emanuele Bonetti, Maria R Ippolito, Chiara Soriani, Paolo D'Amico, Simona Rodighiero, Giuseppe Curigliano, Stefano Santaguida, Massimo Cristofanilli, Pier Giuseppe Pelicci, Luca Mazzarella
Publikováno v:
Cancer Research. 82:P5-13
Background: Despite major technological and conceptual advancements, treatment decisions in HER2+ metastatic breast cancer (mBC) remain largely based on clinical evidence, with no established predictive biomarkers to direct treatment for individual p
Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma
Autor:
Federica Parodi, Alessandra Boletta, Giulio Donati, Bruno Amati, Christopher P. Vellano, Giulio Draetta, Micol Ravà, Joseph R. Marszalek, Alessandro Verrecchia, Paola Nicoli, Mirko Doni, Simona Rodighiero, Marco Filipuzzi, Laura Cassina
Publikováno v:
Molecular Oncology. 16:1132-1152
Multiple molecular features, such as activation of specific oncogenes (e.g., MYC, BCL2) or a variety of gene expression signatures, have been associated with disease course in diffuse large B-cell lymphoma (DLBCL), although their relationships and im
Autor:
Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati
MYC is a key oncogenic driver and an adverse prognostic factor in multiple types of cancer, including diffuse large B-cell lymphoma (DLBCL). Yet, MYC activation also endows cancer cells with a series of metabolic dependencies, which can provide strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e075273513e572bfc05f56cd02625742
https://doi.org/10.1101/2022.06.21.497021
https://doi.org/10.1101/2022.06.21.497021
Autor:
Bruno A. Duso, Eleonora Messuti, Emanuele Bonetti, Giulia Tini, Alessia Castiglioni, Giuseppe Ciossani, Silvia Monzani, Chiara Soriani, Simona Rodighiero, Luigi Scietti, Costantino Jemos, Luca Mazzarella
Publikováno v:
Cancer Research. 83:4896-4896
The tumor suppressor NF1 is classically considered a negative RAS regulator, but sparse evidence suggests additional RAS-independent roles. Early studies suggested an interaction with tubulin, which remains poorly characterized to date but may be of
Autor:
Carina B. Nava Lauson, Silvia Tiberti, Paola A. Corsetto, Federica Conte, Punit Tyagi, Markus Machwirth, Stefan Ebert, Alessia Loffreda, Lukas Scheller, Dalia Sheta, Zeinab Mokhtari, Timo Peters, Ayush T. Raman, Francesco Greco, Angela M. Rizzo, Andreas Beilhack, Giovanni Signore, Nicola Tumino, Paola Vacca, Liam A. McDonnell, Andrea Raimondi, Philip D. Greenberg, Johannes B. Huppa, Simone Cardaci, Ignazio Caruana, Simona Rodighiero, Luigi Nezi, Teresa Manzo
Publikováno v:
Cell Metabolism. 35:633-650.e9